De‐Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion‐dependent myelodysplastic syndromes

Sally Killick, Aimee Jackson, Helen Coulthard, Christina Yap, Emma Das‐Gupta, Dudley J. Pennell, John Porter, David Bowen, Dominic Culligan

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalBritish Journal of Haematology
DOIs
Publication statusPublished - Jun 2020

Cite this